Pyridostigmine and pyridoxine are promising treatment option in cases of vincristine-induced neuropathy. (Turk J Ophthalmol 2014; 44: 330-1)
📌 3 Key Takeaways
🎯
Objective & Hypothesis:Summary In this manuscript, we present the case of a patient with acute lymphoblastic leukemia who developed vincristine-induced bilateral ptosis and external ophthalmoplegia and who was treated successfully with pyridoxine and pyridostigmine.
📊
Key Findings & Data:Summary In this manuscript, we present the case of a patient with acute lymphoblastic leukemia who developed vincristine-induced bilateral ptosis and external ophthalmoplegia and who was treated successfully with pyridoxine and pyridostigmine.
💡
Conclusion & Impact:Pyridostigmine and pyridoxine are promising treatment option in cases of vincristine-induced neuropathy. (Turk J Ophthalmol 2014; 44: 330-1)
🔬Design:Research Article
📍Scope:2014 Verileri
⚙️Variables:Domain Parameters
Abstract
Summary In this manuscript, we present the case of a patient with acute lymphoblastic leukemia who developed vincristine-induced bilateral ptosis and external ophthalmoplegia and who was treated successfully with pyridoxine and pyridostigmine. Pyridostigmine and pyridoxine are promising treatment option in cases of vincristine-induced neuropathy. (Turk J Ophthalmol 2014; 44: 330-1)
Özet
Vinkristine bağlı bilateral ptosis ve ekstarnal oftalmopleji gelişen akut lenfoblastik lösemili vakada başarılı pridoksin ve pridostigmin tedavisini sunmayı amaçladık. Vinkristine bağlı nöropati iyileşmesinde pridostigmin ve pridoksin umut verici tedavi seçeneğidir. (Turk J Ophthalmol 2014; 44: 330-1)
🔖
Cite This Article
KIVANÇ, S. A., ALTUN, A., OLCAYSU, O. O., OLCAYSU, E., KESKİN, Z. Y. (2022). Vinkristine bağlı bilateral ptosis ve eksternal oftalmopleji tedavisinde pridoksin ve pridostigmin etkinliği: Olgu Sunumu. Türk Oftalmoloji Dergisi, Cilt: 44 - Sayı: 4, 330–331. https://ajindex.com/articles/638029
Rowinsky EK, Donehower RC. The clinical pharmacology and useantimicrotubule agents in cancer chemotherapeutics. Pharmacol Ther. 1991;52:35-84.
Dixit G, Dhingra A, Kaushal D. Vincristine induced cranial neuropathy.Assoc Physicians India. 2012;60:56-8.
Bay A, Yilmaz C, Yilmaz N, Oner AF. Vincristine induced cranial polyneuropathy. Indian J Pediatr. 2006;73:531-3.
Jaggi AS, Singh N. Mechanisms in cancer-chemotherapeutic drugs-induced peripheral neuropathy. Toxicology. 2012;291:1-9. Chan JD. Pharmacokinetic drug interactions of vinca alkaloids: summarycase reports. Pharmacotherapy. 1998;18:1304-7.
Reinders-Messelink HA, Van Weerden TW, Fock JM, et al. Mild axonal neuropathy of children during treatment for acute lymphoblastic leukemia. European J Paed Neurol. 2000;4:225-33.
Jeng MR, Feusner J. Itraconazole-enhanced vincristine neurotoxicity in a child with acute lymphoblastic leukemia. Pediatr Hematol Oncol. 2001;18:137-42.
Gursel O, Sari E, Altun D, Atay AA, Akin R. Vincristine-Induced unilateral ptosis in a child. Pediatr Neurol. 2009;41:461-3.
Batta B, Trechot F, George JL, Angioi K. Vincristine-induced unilateral ptosis. Acta Ophthalmologica. 2012;90:249. Müller L, Kramm CM, Tenenbaum T, Wessalowski R, Göbel U. Treatment of vincristine-induced bilateral ptosis with pyridoxine and pyridostigmine. Pediatr Blood Cancer. 2004;42:287-88.
Dejan S, Dragana B, Ivana P, Borivoje B, Marko P. Vincristine induced unilateral ptosis. J Pediatr Hematol Oncol. 2009;3:463.